Stocks to Watch: MNKD, NKTR

MannKind Corp. (MNKD) shares gained more than 6% Wednesday after the company announced the completion of a phase-III study on Afrezza, its diabetes candidate. MannKind’s stock, which has been uptrending strong for the last eight months, with shares moving higher from its low of $1.82 to its recent high of $7.02, got an immediate boost [...] View the full post at: Stocks to Watch: MNKD, NKTR Related posts: Stocks End Mixed In Choppy Session Merrill’s Largest Shareholder Sees Value in U.S. Banking Stocks Stocks Pause After Last Week’s Rally